Literature DB >> 33484327

Bilateral vestibulopathy in anti-IgLON5 disease.

Christoph Helmchen1,2, Klaus-Peter Wandinger3, Armin Steffen4, Thomas F Münte5,6, Norbert Brüggemann5,7,6.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33484327      PMCID： PMC7914230          DOI： 10.1007/s00415-020-10386-5

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  10 in total

1.  Dystonia, lower limb stiffness, and upward gaze palsy in a patient with IgLON5 antibodies.

Authors:  Norbert Brüggemann; Klaus-Peter Wandinger; Carles Gaig; Andreas Sprenger; Klaus Junghanns; Christoph Helmchen; Alexander Münchau
Journal:  Mov Disord       Date:  2016-03-31       Impact factor: 10.338

2.  IgLON5 antibodies are infrequent in patients with isolated sleep apnea.

Authors:  K Hasselbacher; A Steffen; K-P Wandinger; N Brüggemann
Journal:  Eur J Neurol       Date:  2018-04       Impact factor: 6.089

3.  Clinical manifestations of the anti-IgLON5 disease.

Authors:  Carles Gaig; Francesc Graus; Yarko Compta; Birgit Högl; Luis Bataller; Norbert Brüggemann; Caroline Giordana; Anna Heidbreder; Katya Kotschet; Jan Lewerenz; Stefan Macher; Maria J Martí; Teresa Montojo; Jesus Pérez-Pérez; Inmaculada Puertas; Caspar Seitz; Mateus Simabukuro; Nieves Téllez; Klaus-Peter Wandinger; Alex Iranzo; Guadalupe Ercilla; Lidia Sabater; Joan Santamaría; Josep Dalmau
Journal:  Neurology       Date:  2017-04-05       Impact factor: 9.910

4.  Clinical spectrum of the pentanucleotide repeat expansion in the RFC1 gene in ataxia syndromes.

Authors:  Maria Gisatulin; Valerija Dobricic; Christine Zühlke; Yorck Hellenbroich; Vera Tadic; Alexander Münchau; Klaus Isenhardt; Katrin Bürk; Melanie Bahlo; Paul J Lockhart; Katja Lohmann; Christoph Helmchen; Norbert Brüggemann
Journal:  Neurology       Date:  2020-09-01       Impact factor: 9.910

5.  A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study.

Authors:  Lidia Sabater; Carles Gaig; Ellen Gelpi; Luis Bataller; Jan Lewerenz; Estefanía Torres-Vega; Angeles Contreras; Bruno Giometto; Yaroslau Compta; Cristina Embid; Isabel Vilaseca; Alex Iranzo; Joan Santamaría; Josep Dalmau; Francesc Graus
Journal:  Lancet Neurol       Date:  2014-04-03       Impact factor: 44.182

6.  Neuropathological criteria of anti-IgLON5-related tauopathy.

Authors:  Ellen Gelpi; Romana Höftberger; Francesc Graus; Helen Ling; Janice L Holton; Timothy Dawson; Mara Popovic; Janja Pretnar-Oblak; Birgit Högl; Erich Schmutzhard; Werner Poewe; Gerda Ricken; Joan Santamaria; Josep Dalmau; Herbert Budka; Tamas Revesz; Gabor G Kovacs
Journal:  Acta Neuropathol       Date:  2016-06-29       Impact factor: 17.088

7.  Postural Control in Bilateral Vestibular Failure: Its Relation to Visual, Proprioceptive, Vestibular, and Cognitive Input.

Authors:  Andreas Sprenger; Jann F Wojak; Nico M Jandl; Christoph Helmchen
Journal:  Front Neurol       Date:  2017-09-01       Impact factor: 4.003

8.  Anti-IgLON5 Disease: A Case With 11-Year Clinical Course and Review of the Literature.

Authors:  Mette Scheller Nissen; Morten Blaabjerg
Journal:  Front Neurol       Date:  2019-10-02       Impact factor: 4.003

Review 9.  Recent advances in idiopathic bilateral vestibulopathy: a literature review.

Authors:  Chisato Fujimoto; Masato Yagi; Toshihisa Murofushi
Journal:  Orphanet J Rare Dis       Date:  2019-08-19       Impact factor: 4.123

10.  IgLON5 antibody: Neurological accompaniments and outcomes in 20 patients.

Authors:  Josephe A Honorat; Lars Komorowski; Keith A Josephs; Kai Fechner; Erik K St Louis; Shannon R Hinson; Sabine Lederer; Neeraj Kumar; Avi Gadoth; Vanda A Lennon; Sean J Pittock; Andrew McKeon
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2017-07-18
  10 in total
  2 in total

1.  Ocular Motor Abnormalities in Anti-IgLON5 Disease.

Authors:  Stefan Macher; Ivan Milenkovic; Tobias Zrzavy; Romana Höftberger; Stefan Seidel; Evelyn Berger-Sieczkowski; Thomas Berger; Paulus S Rommer; Gerald Wiest
Journal:  Front Immunol       Date:  2021-09-30       Impact factor: 7.561

Review 2.  Anti-IgLON5 Disease - The Current State of Knowledge and Further Perspectives.

Authors:  Natalia Madetko; Weronika Marzec; Agata Kowalska; Dominika Przewodowska; Piotr Alster; Dariusz Koziorowski
Journal:  Front Immunol       Date:  2022-03-01       Impact factor: 7.561
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.